The impact of chronic hepatitis C on resource utilisation and in-patient mortality for Medicare beneficiaries between 2005 and 2010

被引:29
|
作者
Younossi, Z. M. [1 ,2 ]
Stepanova, M. [2 ]
Mishra, A. [1 ]
Venkatesan, C. [1 ]
Henry, L. [2 ]
Hunt, S. [1 ,2 ]
机构
[1] Inova Fairfax Hosp, Dept Med, Falls Church, VA USA
[2] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
关键词
QUALITY-OF-LIFE; DUAL ELIGIBLES; COST; EPIDEMIOLOGY; VIRUS;
D O I
10.1111/apt.12485
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundAs baby boomers age, chronic hepatitis C (CHC) will become increasingly important in Medicare eligible group. AimTo evaluate trends in Medicare resource utilisation for CHC. MethodsWe analysed the Medicare in-patient and out-patient data from 2005 to 2010. For each patient, all claims with CHC as a principal diagnosis were added up and yearly CHC-related spending was calculated. ResultsA total of 48880 out-patient claims for 21655 CHC patients and 4884 hospital admission claims for 3092 patients were included. The number of in-patient (1.5-1.6/year) or out-patient (2.2-2.3/year) visits per patient did not change over time, nor did the demographic characteristics of the CHC population. The majority of this population was eligible for Medicare based on disability and the average number of diagnoses per in-patient claim (from 8.11 in 2005 to 8.60 in 2010) and per out-patient claim (from 2.18 in 2005 to 2.71 in 2010) increased (both P<0.0001). The average total yearly spending per patient increased in the out-patient setting from $488 in 2005 to $584 in 2010 (P=0.0132) and did not change in the in-patient setting (from $22245 in 2005 to $23383 in 2010, P=0.14). In the multivariate analysis, the number of diagnoses and conditions per claim and the number of in-patient or out-patient procedures per year were the important independent predictors of increased resource utilisation. ConclusionsMost Medicare beneficiaries with chronic hepatitis C who sought in-patient or out-patient care in 2005-2010 had received Medicare for disability. Although the total resource utilisation did not change, the proportion of patient's responsibility increased.
引用
收藏
页码:1065 / 1075
页数:11
相关论文
共 50 条
  • [41] In chronic hepatitis C, delays between diagnosis and treatment are linked to the doctor-patient relationship
    Enel, Catherine
    Minello, Anne
    Jooste, Valerie
    Pinoit, Jean-Michel
    Hillon, Patrick
    M S-MEDECINE SCIENCES, 2009, 25 (05): : 519 - 523
  • [42] Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication
    Younossi, Zobair M.
    Stepanova, Maria
    Younossi, Issah
    Papatheodoridis, George
    Janssen, Harry L. A.
    Agarwal, Kosh
    Nguyen, Mindie H.
    Gane, Ed
    Tsai, Naoky
    Nader, Fatema
    LIVER INTERNATIONAL, 2019, 39 (10) : 1837 - 1844
  • [43] The impact of the new antiviral regimens on patient reported outcomes and health economics of patients with chronic hepatitis C
    Younossi, Zobair
    Henry, Linda
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S186 - S196
  • [44] Impact of SVR on all-cause and liver-related mortality in a cohort of Veterans with chronic hepatitis C
    Dieperink, Eric
    Ho, Samuel B.
    Thuras, Paul
    Colton, Samuel
    Knott, Astrid
    Pocha, Christine
    HEPATOLOGY, 2012, 56 : 680A - 680A
  • [45] Impact of Direct-Acting Antiviral Therapy on All-Cause Mortality in Chronic Hepatitis C Patients
    Tang, Wei-Zhen
    Huang, Kang-Jin
    Liu, Tai-Hang
    LIVER INTERNATIONAL, 2025, 45 (04)
  • [46] Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010
    Allison, Robert D.
    Tong, Xin
    Moorman, Anne C.
    Ly, Kathleen N.
    Rupp, Loralee
    Xu, Fujie
    Gordon, Stuart C.
    Holmberg, Scott D.
    JOURNAL OF HEPATOLOGY, 2015, 63 (04) : 822 - 828
  • [47] German nation-wide in-patient treatment of abdominal aortic aneurysm—trends between 2005 and 2019 and impact of the SARS-CoV-2 pandemic
    Stefanie Bette
    Josua A. Decker
    Sebastian Zerwes
    Yvonne Gosslau
    Dominik Liebetrau
    Alexander Hyhlik-Duerr
    Florian Schwarz
    Thomas J. Kroencke
    Christian Scheurig-Muenkler
    CVIR Endovascular, 6
  • [48] Retrospective cohort study of liver transplantation in the United Kingdom between 1994 and 2010: the impact of hepatitis C infection
    Edeghere, O.
    Verlander, N. Q.
    Aboulhab, J.
    Costella, A.
    Harris, H. E.
    Balogun, M. A.
    Ramsay, M. E.
    PUBLIC HEALTH, 2015, 129 (05) : 509 - 516
  • [49] The impact of direct antiviral agent therapy on liver fibrosis in patient with advanced fibrosis related chronic hepatitis C
    Kutala, B.
    Darrigrand, N. B.
    Corinne, C.
    Pierre, B.
    Asselah, T.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S541 - S541
  • [50] Patient-reported outcomes in chronic hepatitis C: The impact of placebo, active treatment, and sustained viral eradication
    Younossi, Z.
    Stepanova, M.
    Manns, M. P.
    Reddy, R.
    Gordon, S. C.
    Bourliere, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S312 - S312